微粉化
溶解度
增溶
超临界流体
化学
生物利用度
药物输送
药品
材料科学
生物制药
药理学
有机化学
粒径
医学
物理化学
生物
生物化学
遗传学
作者
Kifayat Ullah Khan,Muhammad Usman Minhas,Syed Faisal Badshah,Muhammad Suhail,Aousaf Ahmad,S. Ijaz
出处
期刊:Life Sciences
[Elsevier]
日期:2022-02-01
卷期号:291: 120301-120301
被引量:88
标识
DOI:10.1016/j.lfs.2022.120301
摘要
Poor aqueous solubility and poor bioavailability are major issues with many pharmaceutical industries. By some estimation, 70-90% drug candidates in development stage while up-to 40% of the marketed products are poorly soluble which leads to low bioavailability, reduced therapeutic effects and dosage escalation. That's why solubility is an important factor to consider during design and manufacturing of the pharmaceutical products. To-date, various strategies have been explored to tackle the issue of poor solubility. This review article focuses the updated overview of commonly used macro and nano drug delivery systems and techniques such as micronization, solid dispersion (SD), supercritical fluid (SCF), hydrotropy, co-solvency, micellar solubilization, cryogenic technique, inclusion complex formation-based techniques, nanosuspension, solid lipid nanoparticles, and nanogels/nanomatrices explored for solubility enhancement of poorly soluble drugs. Among various techniques, nanomatrices were found a promising and impeccable strategy for solubility enhancement of poorly soluble drugs. This article also describes the mechanism of action of each technique used in solubilization enhancement.
科研通智能强力驱动
Strongly Powered by AbleSci AI